ADCs: A Primer for the Pharmaceutical Industry
Nearly two dozen antibody drug conjugates (ADCs) have now been approved worldwide and revenues were already well into the tens of billions in 2024. Now a serious commercial force in the pharmaceutical industry, what do businesses need to know?
